期刊文献+

慢性肾衰竭患者左心室肥厚危险因素分析 被引量:2

下载PDF
导出
摘要 目的探讨慢性肾衰竭患者左心室肥厚的相关危险因素。方法通过对72例慢性肾衰竭患者的临床资料进行回顾性分析对比。结果 72例慢性肾衰竭患者中有34例(47.2%)发生左心室肥厚,且随着肾功能损害的加重,左心室肥厚发生有逐渐增多趋势。左心室肥厚的发生与收缩压、血磷浓度升高及血红蛋白的降低有显著相关(P<0.05),而与患者年龄、舒张压、血清清蛋白、血糖、血脂无明显相关(P>0.05)。结论慢性肾衰竭患者左心室肥厚与收缩压、血红蛋白、血磷等危险因素相关,积极控制血压、纠正贫血和钙磷代谢紊乱等,对减少心血管事件发生有重要的临床意义。
出处 《安徽医学》 2011年第12期2036-2037,共2页 Anhui Medical Journal
  • 引文网络
  • 相关文献

参考文献8

  • 1Centers for disease control and prevention (CDC).State-specific trends in chronic kidney failure (United States, 1990-2001 ). MMWR Morb Mortal Wkly Rep, 2004,53 (39) : 918-920.
  • 2Locatelli F, Marcelli D, Conte F, et al. Cardiovascular disease in chronic renal failure.Nephrol Dial Transplant, 2000,15 (5) : 69 - 80.
  • 3叶任高.临床肾脏病学.2版.北京:人民卫生出版社,2008:44.
  • 4侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量:183
  • 5Weir MR.The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease.Am J Hypertens, 2005,18 (4Pt2) : S 100-S 105.
  • 6Modhnmath R, Brian JG.Pereira prospective trials on anemia of chronic disease:The train to reduce cardiovascular events with Aranesp therepy.Kidney Int, 2003,64( Suppl 87 ) : 12-19.
  • 7FujiiH,Kim JI,Abe T,et al Relationship between parathyroid hormone and cardiac abnormalities in chronic dialysis patients. Intem Med,2007,46(18) : 1507-1512.
  • 8张莉,黄扬扬.慢性肾衰竭维持性透析患者的C-反应蛋白的变化及相关因素分析[J].安徽医学,2007,28(6):537-538. 被引量:6

二级参考文献20

  • 1侯凡凡.慢性肾脏病的心血管并发症[J].中华心血管病杂志,2004,32:16-16.
  • 2何长民 张训 见:何长民 张训主编.前言[A].见:何长民,张训主编.肾脏替代治疗学[C].上海:上海科学技术文献出版社,1999.2..
  • 3Locatelli F, Pozzoni P, Tentori F, et al. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant, 2003,18 Suppl 7:2-9.
  • 4Muntner P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol, 2002,13:745-753.
  • 5Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol, 2003,41:47-55.
  • 6Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int, 1995,47:186-192.
  • 7Sarnak MJ, Levey AS, Schoolwerth AC,et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation, 2003,108:2154-2169.
  • 8Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 Study. Kidney Int, 2003,63:1462-1467.
  • 9Wong JS, Rort FK, Hulbert-Shearon TE, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int, 1999,55:2515-2523.
  • 10Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998,32:s112-s119.

共引文献186

同被引文献19

引证文献2

二级引证文献4

相关主题

;
使用帮助 返回顶部